Placebo Solution for injection or infusion 0 mg/1 mL clinical trials

A randomized, subject and investigator blinded, placebo controlled and multi-center platform study, to assess efficacy and safety of different investigational drugs in patients with moderate to severe hidradenitis suppurativa

This study is testing new medicines for people with moderate to severe hidradenitis suppurativa, a skin condition. Researchers want to see if the new medicines can improve symptoms and are safe, compared to a dummy treatment.